Veradermics, Incorporated (MANE)

Veradermics Statistics

Total Valuation

Veradermics has a market cap or net worth of $2.85 billion. The enterprise value is $2.71 billion.

Market Cap	2.85B
Enterprise Value	2.71B

Important Dates

The last earnings date was Monday, March 30, 2026, before market open.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Veradermics has 37.34 million shares outstanding.

Current Share Class	37.34M
Shares Outstanding	37.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.74%
Owned by Insiders (%)	4.50%
Owned by Institutions (%)	5.63%
Float	20.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	19.86
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.66, with a Debt / Equity ratio of 0.00.

Current Ratio	16.66
Quick Ratio	15.64
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -72.06% and return on invested capital (ROIC) is -46.55%.

Return on Equity (ROE)	-72.06%
Return on Assets (ROA)	-43.45%
Return on Invested Capital (ROIC)	-46.55%
Return on Capital Employed (ROCE)	-50.43%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$4.39M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	54.74
200-Day Moving Average	n/a
Relative Strength Index (RSI)	64.84
Average Volume (20 Days)	514,312

Short Selling Information

The latest short interest is 2.32 million, so 6.21% of the outstanding shares have been sold short.

Short Interest	2.32M
Short Previous Month	1.27M
Short % of Shares Out	6.21%
Short % of Float	11.39%
Short Ratio (days to cover)	5.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-72.35M
Pretax Income	-70.00M
Net Income	-83.37M
EBITDA	n/a
EBIT	-72.35M
Earnings Per Share (EPS)	-$111.91

Balance Sheet

The company has $141.86 million in cash and $4,000 in debt, with a net cash position of $141.86 million or $3.80 per share.

Cash & Cash Equivalents	141.86M
Total Debt	4,000
Net Cash	141.86M
Net Cash Per Share	$3.80
Equity (Book Value)	143.46M
Book Value Per Share	-163.87
Working Capital	143.34M

Cash Flow

In the last 12 months, operating cash flow was -$71.60 million and capital expenditures -$24,000, giving a free cash flow of -$71.63 million.

Operating Cash Flow	-71.60M
Capital Expenditures	-24,000
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-71.63M
FCF Per Share	-$1.92

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Veradermics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.93%
FCF Yield	-2.51%

Analyst Forecast

The average price target for Veradermics is $78.33, which is 2.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$78.33
Price Target Difference	2.67%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1